Smilax glabra Roxb.: A Review of Its Traditional Usages, Phytochemical Constituents, Pharmacological Properties, and Clinical Applications
Hao Wu,Yu Wang,Bing Zhang,Yao-lei Li,Zhi-xin Ren,Jing-jian Huang,Zhi-qi Zhang,Zhi-jian Lin,Xiao-meng Zhang
DOI: https://doi.org/10.2147/DDDT.S374439
2022-10-19
Abstract:Hao Wu, 1, &ast Yu Wang, 1, &ast Bing Zhang, 1, 2 Yao-lei Li, 1 Zhi-xin Ren, 1 Jing-jian Huang, 1 Zhi-qi Zhang, 1 Zhi-jian Lin, 1 Xiao-meng Zhang 1 1 Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 2 Center for Pharmacovigilance and Rational Use of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Bing Zhang, Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, South Yang-Guang Road, Fang-shan District, Beijing, 100029, People's Republic of China, Email Smilax glabra Roxb . (SGB) is a medicinal plant widely distributed in 17 countries worldwide. It is the primary raw material of the world-famous and best-selling functional food and beneficial tea. SGB was first recorded in Ben Cao Jing Ji Zhu of the Southern and Northern Dynasties (420– 589 AD) and was reported for nutritional and medicinal properties for thousands of years. This review searched PubMed, Web of Science, and other databases for relevant literature on SGB species until April 2022. It aims to provide more integrated thinking, detailed awareness, and better knowledge of SGB. More than 200 chemical components have been discovered, including flavonoids, phenolic, phenolic acids, stilbenes, organic acids, phenylpropanoids, and others. Previous studies have demonstrated that SGB and its active ingredients show a wide range of pharmacological effects, including anti-infective, anti-cancer, anti-inflammatory, antioxidant, cardiovascular protection, etc. However, many studies on the biological activity of this plant were mainly based on crude extracts and active ingredients, and there is a lack of clinical studies and toxicity studies to support the development of drug design, development, and therapy. In summary, this review will provide specific and valuable suggestions and guidelines for further research and application of this plant in the medicinal field. Keywords: Smilax glabra Roxb, astilbin, traditional usages, phytochemical constituents, pharmacological properties, clinical applications Smilax glabra Roxb. (SGB) is the rhizome of the Liliaceae plant, named Tu fuling in Chinese. There are more than 300 species of the Smilax genus in the world, most of which grow on hillsides, barren hills, and semi-shady land near forests. 1 They are rich in resources and are widely distributed in 17 countries globally, including Asia, Europe, South America, etc. And it has been used as food and folk medicine in many countries for a long time. SGB has been widely used worldwide due to its evident pharmacological activity for treating syphilitic, poisoned sores, pathological leucorrhea, eczema itching, carbuncle poisoning, and other diseases. 2–4 Modern research has shown that SGB mainly includes flavonoids, 5–8 phenolic and phenolic aids, 9,10 stilbene and organic acids, 11–13 phenylpropanoids, 13,14 and others. 14–16 Pharmacological studies have shown that the active ingredients in SGB have a variety of pharmacological effects, including anti-infective, 17–19 anti-cancer, 20–22 anti-inflammatory, 16,23,24 antioxidant, 25,26 and cardiovascular protection etc. 27–29 Simultaneously, SGB is the primary raw material of the world-famous and best-selling functional food, soup and beneficial tea. It has the functions of nourishing yin and detoxification due to heat and humidity. In addition, the rhizome of SGB is rich in starch and can also be used to make cakes or winemaking. 30–33 This product is cylindrical, flat or irregular, with nodular swelling, short branches, 5–22cm in length and 2–5cm in diameter. The surface is yellow-brown or gray-brown, uneven, with hard, fibrous root residues, round bud marks on the top of the branches, irregular cracks in the outer skin, and residual scales and leaves. The slices are elliptical or irregular, 1–5mm thick, with rough edges; the cut surface is white to light reddish brown, powdery, punctate vascular bundles. This study conducted the latest and most comprehensive review of SGB, focusing on its traditional usages, phytochemical constituents, pharmacological properties, and clinical applications. It provides a basis for studying pharmacological and phytochemicals' biological activity. This review aims to ensure the medicinal safety of SGB and provide guidance for its application in the medicinal field. This review se -Abstract Truncated-